Please login to the form below
Acquisition
This page shows the latest Acquisition news and features for those working in and with pharma, biotech and healthcare.
Novo Nordisk to buy Dicerna Pharmaceuticals for $3.3bn
The acquisition of Dicerna accelerates Novo Nordisk’s research within RNAi and expands the usage of the RNAi technology,” said Professor Marcus Schindler, chief scientific officer at Novo Nordisk.
Latest news
-
Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
Executing value-enhancing business development is a top priority, and we intend to add to our pipeline through acquisitions, partnerships, licensing deals and collaborations.
-
AZ raises full-year guidance after completing Alexion acquisition in Q2
AstraZeneca has announced that it will raise its full-year 2021 guidance to reflect a boost to its portfolio following the successful acquisition of rare disease company Alexion in the second ... Looking ahead to its full-year results, however, AZ is
-
Resilience acquires bluebird bio’s manufacturing facility as part of cell therapy alliance
Resilience is set to continue investment in the advancement of new technologies and will also expand the workforce upon completion of the acquisition.
-
Amgen pays $900m upfront to acquire Teneobio’s antibody assets, R&D technologies
Following the acquisition, Amgen will also gain Teneobio’s portfolio of antibody assets for oncology targets, which includes the phase 1 trial candidate TNB-585. ... Prior to closing of the Amgen/Teneobio acquisition, three Teneobio affiliate companies
-
AZ’s PNH therapy Ultomiris wins EU backing to expand use for children
In July, AZ completed its acquisition of Alexion, establishing the company as its specialist rare disease unit.
More from news
Approximately 198 fully matching, plus 1,280 partially matching documents found.
Latest Intelligence
-
Integrating competitive intelligence into business development, licensing and M&A strategy
In many circumstances, there is a need to make assessments of potential acquisition targets without the acquiree being aware of the initial interest. ... In the acquisition assessment process, the development of a TPP is a collaborative effort between
-
Back to the future
Equally, large firms have been slow to adapt both to new technologies and changing customer needs and have resorted to acquisition over organic evolution.
-
Transforming clinical trial data into a long-term asset
On the corporate side, it can come into play in licensing and partnership opportunities, in handling legal challenges and due diligence, and in mergers and acquisitions.
-
Sourcing R&D innovation: why pharma companies need to evolve their business models
the pipeline, the use of technology in medicine is expected to grow and so are the associated deals, mergers and acquisitions. ... They also can help identify collaboration opportunities including partnerships, licensing deals and merger or acquisition
-
After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream
Another example is Biogen’s $800m acquisition of Nightstar’s late-stage gene therapy assets for retinal disease – NSR-REP1 and NSR-RPGR.
More from intelligence
Approximately 75 fully matching, plus 95 partially matching documents found.
Latest appointments
-
Fishawack Health restructures creative team
In February, Fishawack announced its acquisition of The Hive Health Group, a healthcare marketing and scientific communications agency with a presence in both the UK and US.
-
Ashfield Advisory adds Mary-Kate McGarry and Emer Jameson to senior leadership team
At Ashfield Advisory, she will be responsible for driving all aspects of the company’s strategy and will work closely with the mergers and acquisitions team, while also oversee the ... We have a strong growth trajectory and plan to accelerate this by
-
Anna Korving joins Resonant Group as non-executive director
Industry veteran Korving previously took a group of agencies from start up through to acquisition by Publicis Health, to create the integrate service offerings Publicis Life Brands Resolute – now known as
-
AZ appoints Alexion’s Aradhana Sarin as chief financial officer
Sarin will become AZ's new chief financial officer upon closing of the company’s acquisition of Alexion Pharmaceuticals. ... At AZ, she will succeed current chief financial officer Marc Dunoyer, who will step down from the role and retire from the
-
Deborah Keller appointed as chair of Fishawack Health’s board
Keller’s appointment follows a number of recent acquisitions at Fishawack, including the healthcare marketing and scientific communications agency The Hive Health Group and the global market access consultancy PRMA Consulting.
More from appointments
Approximately 0 fully matching, plus 124 partially matching documents found.
Latest from PMHub
-
Fishawack Health appoints new CEO, Jonathan Koch
The company was founded by Oliver Dennis and Dominic Miller in 2001 and over the last two decades has grown rapidly through organic strategies and the acquisition of 16 companies spanning ... We have achieved tremendous growth through extensive client
-
Day in a #LucidLife - Meet Nick
thinking individuals all united by a common goal to TRANSFORM LIVES - please get in touch with one of our talent acquisition managers: Daniel Newbury, Ellen Field Assoc CIPD or Jon Turner
-
Attracting the best talent to build Lucid’s future
The business has gone through multiple acquisitions over the last 2 years, backed by private equity investment.
-
OPEN Health Acquires ARK
OPEN Health has today announced the acquisition of London-based agency ARK to further strengthen omnichannel capabilities. ... Joining forces to further strengthen our omnichannel capabilities. September 23, 2021, London, UK –OPEN Health has today
-
Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role
The organization has designed a robust organic growth, talent development, and acquisition strategy to continuously build its team of the best-of-the-best medical, marketing and market access experts, delivering
OPEN Health Acquires ARK
More from PMHub
Approximately 13 fully matching, plus 105 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- First trial of a vaccine against Alzheimer’s launches
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- Gilead to pay $745m for three oncology programmes from Arcus Biosciences
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting
- Lucid Group: Orange the World
- First trial of a vaccine against Alzheimer’s launches
- New COVID variant causing concern
- PMEA 2021: A Celebration of Excellence in Patient Engagement
- From Academics to Entrepreneurship: How Tech is Revolutionizing the Diagnostics Landscape
- Impetus Digital wins Canada’s Most Admired Corporate Cultures Awards 2021
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Biogen’s Aduhelm unlikely to get approval in Europe
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- The pandemic preparedness paradox
- First trial of a vaccine against Alzheimer’s launches
- Good NICE news for Pfizer, but Dendreon drug rejected
PMHub
Page & Page and Partners
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...
Latest intelligence
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
- Six ways to improve diversity in clinical trials
- Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...
